These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 21469146
1. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer. Chen JS, Su IJ, Leu YW, Young KC, Sun HS. Int J Cancer; 2012 Mar 15; 130(6):1302-13. PubMed ID: 21469146 [Abstract] [Full Text] [Related]
2. Tiam1 is associated with hepatocellular carcinoma metastasis. Huang J, Ye X, Guan J, Chen B, Li Q, Zheng X, Liu L, Wang S, Ding Y, Ding Y, Chen L. Int J Cancer; 2013 Jan 01; 132(1):90-100. PubMed ID: 22573407 [Abstract] [Full Text] [Related]
3. Sp1-mediated ectopic expression of T-cell lymphoma invasion and metastasis 2 in hepatocellular carcinoma. Yen WH, Ke WS, Hung JJ, Chen TM, Chen JS, Sun HS. Cancer Med; 2016 Mar 01; 5(3):465-77. PubMed ID: 26763486 [Abstract] [Full Text] [Related]
4. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M, Zhang XY, Yu X. Biomed Pharmacother; 2017 Jan 01; 85():348-354. PubMed ID: 27899259 [Abstract] [Full Text] [Related]
5. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition. Dou C, Jin X, Sun L, Zhang B, Han M, Li T. Cancer Biomark; 2017 Jul 04; 19(4):447-454. PubMed ID: 28582850 [Abstract] [Full Text] [Related]
6. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin. Li J, Dai X, Zhang H, Zhang W, Sun S, Gao T, Kou Z, Yu H, Guo Y, Du L, Jiang S, Zhang J, Zhou Y. Oncotarget; 2015 Oct 06; 6(30):29196-208. PubMed ID: 26470691 [Abstract] [Full Text] [Related]
7. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC. J Cell Mol Med; 2011 Mar 06; 15(3):691-700. PubMed ID: 20219012 [Abstract] [Full Text] [Related]
8. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma]. Xu Q, Cai W, Zhang M, Liu Q, Liu X. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar 06; 32(3):387-92. PubMed ID: 26927562 [Abstract] [Full Text] [Related]
9. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z, Xiong Z, Li R, Liang H, Jia C, Deng M. Biomed Pharmacother; 2018 Aug 06; 104():102-109. PubMed ID: 29772429 [Abstract] [Full Text] [Related]
11. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma. Zhou YM, Cao L, Li B, Zhang RX, Sui CJ, Yin ZF, Yang JM. Ann Surg Oncol; 2012 May 06; 19(5):1700-6. PubMed ID: 21584833 [Abstract] [Full Text] [Related]
12. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin. Jiang C, Pecha J, Hoshino I, Ankrapp D, Xiao H. Cancer Res; 2007 Apr 15; 67(8):3574-82. PubMed ID: 17440068 [Abstract] [Full Text] [Related]
13. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma. Zhang XL, Huang CX, Zhang J, Inoue A, Zeng SE, Xiao SJ. Oncol Rep; 2013 Aug 15; 30(2):809-14. PubMed ID: 23756565 [Abstract] [Full Text] [Related]
14. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Wang TH, Lin YS, Chen Y, Yeh CT, Huang YL, Hsieh TH, Shieh TM, Hsueh C, Chen TC. Oncotarget; 2015 Sep 15; 6(27):23342-57. PubMed ID: 26160837 [Abstract] [Full Text] [Related]
15. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling. Lin J, Lin W, Ye Y, Wang L, Chen X, Zang S, Huang A. J Exp Clin Cancer Res; 2017 Sep 29; 36(1):134. PubMed ID: 28969700 [Abstract] [Full Text] [Related]
16. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma. Yan Q, Zhang ZF, Chen XP, Gutmann DH, Xiong M, Xiao ZY, Huang ZY. Int J Oncol; 2008 May 29; 32(5):1057-63. PubMed ID: 18425332 [Abstract] [Full Text] [Related]
17. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT. Zheng X, Gai X, Wu Z, Liu Q, Yao Y. Oncol Rep; 2013 May 29; 29(5):1811-8. PubMed ID: 23483190 [Abstract] [Full Text] [Related]
18. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma. Wang X, Dong J, Jia L, Zhao T, Lang M, Li Z, Lan C, Li X, Hao J, Wang H, Qin T, Huang C, Yang S, Yu M, Ren H. Cancer Lett; 2017 May 01; 393():113-124. PubMed ID: 28153790 [Abstract] [Full Text] [Related]
19. C1orf61 acts as a tumor activator in human hepatocellular carcinoma and is associated with tumorigenesis and metastasis. Hu HM, Chen Y, Liu L, Zhang CG, Wang W, Gong K, Huang Z, Guo MX, Li WX, Li W. FASEB J; 2013 Jan 01; 27(1):163-73. PubMed ID: 23012322 [Abstract] [Full Text] [Related]
20. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin. Lu S, Zhou W, Wei H, He L, Li L. Dig Dis Sci; 2015 Dec 01; 60(12):3681-90. PubMed ID: 26280083 [Abstract] [Full Text] [Related] Page: [Next] [New Search]